Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | NMT1 | P30419 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3038968 | 0.89 | SMN1; SMN2 (0.63) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| Hydrochloric Acid SCHEMBL5133311 | 0.87 | SMN1; SMN2 (0.66) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL14416001 | 0.86 | SMN1; SMN2 (0.45) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL25857294 | 0.86 | SMN1; SMN2 (0.55) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL12424656 | 0.84 | ALDH1A1 (0.59) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL25067265 | 0.82 | TLR8 (0.59) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL25067256 | 0.82 | SMN1; SMN2 (0.55) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A | |
| SCHEMBL25857292 | 0.81 | SMN1; SMN2 (0.58) | SMN1; SMN2KCNH2NMT1CYP2D6TSHR | |
| SCHEMBL26027171 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2TLR8KCNH2CYP2D6TSHR | |
| SCHEMBL18250324 | 0.81 | TLR8 (0.57) | SMN1; SMN2TLR8ALDH1A1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11471821-B2 | Process for biogas upgradation | INDIAN OIL CORPORATION LIMITED (IN) | 2022-10-18 | — | — | US | claimed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | claimed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | claimed |
| EP-1971600-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK Holdings Co., Ltd. (KR) | 2008-09-24 | — | — | EP | claimed |
| WO-2007078113-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK HOLDINGS CO., LTD. (KR) | 2007-07-12 | — | — | WO | claimed |
| WO-2023158738-A2 | LIPID NANOPARTICLES FOR DELIVERY TO THE EYE OR EAR | TRUSTEES OF TUFTS COLLEGE (US) | 2023-08-24 | — | — | WO | disclosed |
| US-20230212629-A1 | COMPOSITIONS AND METHODS FOR PRODUCING CIRCULAR POLYRIBONUCLEOTIDES | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2023-07-06 | — | — | US | disclosed |
| US-11607646-B2 | Process for CO2 capture from gaseous streams | INDIAN OIL CORPORATION LIMITED (IN) | 2023-03-21 | — | — | US | disclosed |
| US-11471821-B2 | Process for biogas upgradation | INDIAN OIL CORPORATION LIMITED (IN) | 2022-10-18 | — | — | US | disclosed |
| US-20210322920-A1 | PROCESS FOR BIOGAS UPGRADATION | INIDAN OIL CORPORATION LIMITED (IN) | 2021-10-21 | — | — | US | disclosed |
| EP-3895783-A1 | PROCESS FOR BIOGAS UPGRADATION | Indian Oil Corporation Limited (IN) | 2021-10-20 | — | — | EP | disclosed |
| EP-3620225-B1 | PROCESS FOR CO2 CAPTURE FROM GASEOUS STREAMS | INDIAN OIL CORP LTD (IN) | 2021-04-28 | — | — | EP | disclosed |
| US-20200070091-A1 | PROCESS FOR CO2 CAPTURE FROM GASEOUS STREAMS | INDIAN OIL CORPORATION LIMITED (IN) | 2020-03-05 | — | — | US | disclosed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | disclosed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | disclosed |
| EP-1971600-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK Holdings Co., Ltd. (KR) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007078113-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK HOLDINGS CO., LTD. (KR) | 2007-07-12 | — | — | WO | disclosed |
| EP-0188999-B1 | CATIONIC REACTION PRODUCTS FROM 1-AMINOALKYL IMIDAZOLE COMPOUNDS AND EPIHALOGEN HYDRINS | CIBA-GEIGY AG (CH) | 1989-05-31 | — | — | EP | disclosed |
| US-4705865-A | Cationic reaction products formed from 1-aminoalkyl-imidazole compounds and epihalohydrins | CIBA-GEIGY CORPORATION (US) | 1987-11-10 | — | — | US | disclosed |
| EP-0188999-A1 | Cationic reaction products from 1-aminoalkyl imidazole compounds and epihalogen hydrins | CIBA-GEIGY AG (CH) | 1986-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | WNT3A, WNT1, WNT3 | SMN1; SMN2 3980/4885TLR8 2096/4885ALDH1A1 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.